Erythema migrans: Three weeks treatment for prevention of late Lyme borreliosis

Infection

Volumn 24, Issue 1, 1996, Pages 69-72

  Breier, F ^a   Kunz, G ^a   Klade, H ^a   Stanek, G ^a   Aberer, E ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MINOCYCLINE; PENICILLIN V;

ADULT; AGED; BORRELIA BURGDORFERI; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; EPIGASTRIC PAIN; ERYTHEMA CHRONICUM MIGRANS; FATIGUE; FEMALE; HUMAN; LYME DISEASE; MALE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BORRELIA BURGDORFERI GROUP; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYME DISEASE; MALE; MIDDLE AGED; MINOCYCLINE; PENICILLINS; PROSPECTIVE STUDIES;

EID: 0030026731     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01780662     Document Type: Conference Paper

References (23)

1. Dattwyler, R. J., Volkman, D. J., Conaty, S. M., Platkin, S. P., Luft, B. J.: Amoxicillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis. Lancet 336 (1990) 1404-1406.
2. Massarotti, E. M., Luger, S. W., Messner, R. P., Wong, J. B., Johnson, R. C., Steere, A. C.: Treatment of early Lyme disease. Am. J. Med. 92 (1992) 396-403.
3. Berger, B. W., Johnson, R. C., Kodner, C., Coleman L.: Failure of Borrelia burgdorferi to survive in the skin of patients with antibiotic-treated Lyme disease. J. Am. Acad. Dermatol. 27 (1992) 34-37.
4. Weber, K., Neubert, U., Thurmayr, R.: Antibiotic therapy in early erythema migrans disease and related disorders. Zbl. Bakt. Hyg. A 263 (1986) 377-388.
5. Liegner, K. B.: Minocycline in Lyme disease. J. Am. Acad. Dermatol. 28 (1993) 131.
6. Goldberg, N. S.: Minocycline in Lyme disease. J. Am. Acad. Dermatol. 28 (1993) 131.
7. Maibach, H.: Second-generation tetracyclines, a dermatologic overview: clinical uses and pharmacology. Cutis 48 (1991) 411-417.
8. Johnson, S. E., Klein, G. C., Schmid, G. P., Feeley, J. C.: Susceptibility of the Lyme disease spirochete to seven antimicrobial agents. Yale J. Biol. Med. 57 (1984) 549-553.
9. Klade, H., Aberer, E.: Late complaints after erythema migrans. J. Spir. Dis. Tick-borne Diseases 1(2) (1994) 52-56.
10. Kersten, A., Poitschek, C., Rauch, S., Aberer, E.: Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi. Antimicrob. Agents Chemother. 39 (1995) 1127-1133.
11. Preac-Mursic, V., Weber, K., Pfister, H. W., Wilske, B., Gross, B., Baumann, A., Prokop, J.: Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection 17 (1989) 355-359.
12. Liegner, K. B., Shapiro, J. R., Ramsay, D., Halperin, A. J., Hogrefe, W., Kong, L.: Recurrent erythema migrans despite extended antibiotic treatment with minocycline in a patient with persisting Borrelia burgdorferi infection. J. Am. Acad. Dermatol. 28 (1993) 312-314.
13. Hartwig, H., Mester, U., Krasemann, C.: Minocyclin-Konzentration im menschlichen Kammerwasser nach oraler Applikation. Klin. Monatsbl. Augenheilkd. 173 (1978) 842-845.
14. Flach, A. J., Lavoie, P. E.: Episcleritis, conjunctivitis, and keratitis as ocular manifestations of Lyme disease. Ophthalmology 97 (1990) 873-875.
15. Berger, B. W., Kaplan, M. H., Rothenberg, I. R., Barbour, A. G.: Isolation and characterisation of the Lyme disease spirochete from skin of patients with erythema chronicum migrans. J. Am. Acad. Dermatol. 13 (1985) 444-449.
16. Grünberger, G.: Alphabetischer Durchstreichtest und Grünberger Verbaler Gedächtnistest. In: Psychodiagnostik des Alkoholkranken. Maudrich, Vienna 1977, pp. 137-162.
17. Kaplan, R. F., Meadows, M. E., Vincent, L. C., Logigian, E. L., Steere, A. C.: Memory impairment and depression in patients with Lyme encephalopathy: comparison with fibromyalgia and nonpsychotically depressed patients. Neurology 42 (1992) 1263-1267.
18. Muellegger, R., Zoechling, N., Soyer, H. P., Hoedl, S., Wienecke, R., Volkenandt, M., Kerl, H.: No detection of Borrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment. Arch. Dermatol. 131 (1995) 678-682.
19. Strle, F., Ruzic, E., Cimperman, J.: Erythema migrans: comparison of treatment with azithromycin, doxycycline and phenoxymethylpenicillin. J. Antimicrob. Chemother. 30 (1992) 543-550.
20. Steere, A.C., Hutchinson, G. J., Rahn, D. W. Sigal, L. H. Crahn, J. E., De Sanna, E. T., Malawista, S. C.: Treatment of early manifestations of Lyme disease. Ann. Intern. Med. 99 (1983) 22-26.
21. Weber, K., Pfister, H. W.: Clinical management of Lyme borreliosis. Lancet 340 (1994) 1017-1020.
22. Dattwyler, R. J-, Halperin, J. J.: Failure of tetracycline therapy in early Lyme disease. Arthritis Rheum. 30 (1987) 448-450.
23. Nadelman, R. B., Luger, S. W., Frank, E., Wisniewski, M., Coffins, J. J., Wormser, G. P.: Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme borreliosis. Ann. Intern. Med. 117 (1992) 273-280.